James Rothman - Net Worth and Insider Trading

James Rothman Net Worth

The estimated net worth of James Rothman is at least $143,971 dollars as of 2024-11-10. James Rothman is the Director of PhenomeX Inc and owns about 144,245 shares of PhenomeX Inc (CELL) stock worth over $143,971. Details can be seen in James Rothman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Rothman has not made any transactions after 2021-11-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of James Rothman

To

James Rothman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James Rothman owns 2 companies in total, including PhenomeX Inc (CELL) , and Adhera Therapeutics Inc (ATRX) .

Click here to see the complete history of James Rothman’s form 4 insider trades.

Insider Ownership Summary of James Rothman

Ticker Comapny Transaction Date Type of Owner
CELL PhenomeX Inc 2021-11-08 director
ATRX Adhera Therapeutics Inc 2008-06-10 director

James Rothman Latest Holdings Summary

James Rothman currently owns a total of 1 stock. James Rothman owns 144,245 shares of PhenomeX Inc (CELL) as of November 8, 2021, with a value of $143,971.

Latest Holdings of James Rothman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CELL PhenomeX Inc 2021-11-08 144,245 1.00 143,971

Holding Weightings of James Rothman


James Rothman Form 4 Trading Tracker

According to the SEC Form 4 filings, James Rothman has made a total of 3 transactions in PhenomeX Inc (CELL) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in PhenomeX Inc is the acquisition of 4,000 shares on November 8, 2021, which cost James Rothman around $97,400.

Insider Trading History of James Rothman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James Rothman Trading Performance

GuruFocus tracks the stock performance after each of James Rothman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Rothman is -67.37%. GuruFocus also compares James Rothman's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Rothman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James Rothman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James Rothman

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -16.5 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -16.49 LIMIT LIMIT LIMIT LIMIT LIMIT

James Rothman Ownership Network

Ownership Network List of James Rothman

No Data

Ownership Network Relation of James Rothman

Insider Network Chart

James Rothman Owned Company Details

What does PhenomeX Inc do?

Who are the key executives at PhenomeX Inc?

James Rothman is the director of PhenomeX Inc. Other key executives at PhenomeX Inc include Chief Financial Officer Mehul Joshi , director & Chief Executive Officer Siddhartha Kadia , and 10 percent owner Bird Mergersub Corp .

PhenomeX Inc (CELL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PhenomeX Inc (CELL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PhenomeX Inc (CELL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PhenomeX Inc (CELL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

PhenomeX Inc Insider Transactions

No Available Data

James Rothman Mailing Address

Above is the net worth, insider trading, and ownership report for James Rothman. You might contact James Rothman via mailing address: 135 East 83rd Street, Apt. 15c, New York Ny 10028.